baber/WOPTO huggingface dataset:
Patent CA-2293735-A1 (CA)
Title: Variants de lag-3 obtenus par epissage
Inventor: TRIEBEL FREDERIC
IPC: C07K14/705
Filed: 1998-06-03
Abstract: L'invention concerne une séquence nucléotidique isolée, choisie dans le groupe comprenant: a) les séquences nucléotidiques SEQ ID NO 1, SEQ ID NO 3 ou SEQ ID NO 5, b) les séquences nucléotidiques qui s'hybrident dans des conditions strictes à l'une quelconque des séquences nommées en a) et qui codent pour un polypeptide qui est un variant de la molécule LAG-3, et c) les séquences nucléotidiques qui sont soumises à une dégénérescence liée au code génétique, afin d'obtenir les séquences nucléotidiques définies en a) et b), et qui codent pour un polypeptide qui est un variant génétique de la molécule LAG-3.
Patent CA-2299332-A1 (CA)
Inventor: INUI MICHIAKI
IPC: B29C35/12
Filed: 1998-08-06
Abstract: Cette invention se rapporte à un procédé de préchauffage d'une plaque polymère consistant à chauffer par induction un stratifié en lui appliquant une tension R.F., suivant sa direction de stratification, par l'intermédiaire d'électrodes. L'invention se rapporte également à un procédé de production d'un stratifié, consistant à chauffer par induction une plaque polymère en appliquant une tension R.F. à un stratifié, suivant sa direction de stratification, par l'intermédiaire d'électrodes, ledit stratifié étant logé à l'intérieur d'un contenant annulaire qui entoure ses surfaces, et à comprimer le stratifié suivant sa direction de stratification, après l'application de la tension R.F. L'invention se rapporte également à un appareil de fabrication de stratifié.
Patent CA-2301162-A1 (CA)
Title: Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
Inventor: GAST MICHAEL JAY
IPC: A61K31/57
Filed: 1998-09-09
Abstract: This invention provides a method of contraception which comprises administering to a female of child bearing age for 28 days per menstrual cycle a combination of a progestin at a daily dosage equivalent to 30-150 µg levornorgestrel and an estrogen at a daily dosage equivalent to 10-20 µg ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, followed by administering a progestin at a daily dosage equivalent to 10-100 µg levornorgestrel for 3-5 days.
Patent CA-2302063-A1 (CA)
Title: Ergonomic chair
Inventor: KMICIKIEWICZ MAREK A
IPC: A47C1/0355
Filed: 2000-03-23
Abstract: A work station chair is enabled to shift in response to a person leaning forward in the chair when in a working mode and leaning back in a rest position.      The chair includes a seat, a backrest and supportive structure. The seat is resiliently supported on the supportive structure and moveably along an arc track which is mounted on the supportive structure and has a radius generated from the ankle of the person sitting on the chair. The backrest is resiliently supported on the seat and moveable along an arc track which is mounted to the seat and has a radius generated from H-point that is a natural pivot point of the torso and thigh lines of the person. The chair provides a combined tilting movement of the person's body about the ankle point and the H-point when the person shifts his or her gravity to reduce adverse static postural loads and forces which are responsible for the fatigue and biomechanical dysfunction. It is also easy to adjust simultaneously the chair and the backrest for different weight loads of persons, which can be done by the person while sitting on the chair and reaching for an adjustment knob in front of the chair.
Patent CA-2303075-A1 (CA)
Inventor: CHAMERLIK MARK A
IPC: C09D11/00
Filed: 1998-09-30
Abstract: The present invention provides a jet ink composition suitable for printing on substrates such as plastics messages having abrasion resistance, the composition comprising an organic solvent, a colorant, a cellulose nitrate resin, and a rosin resin. For example, the messages printed on untreated low density polyethylene and polypropylene substrates have improved rub resistance and scratch resistance. The present invention further provides a method for printing abrasion resistant messages on a surface comprising projecting a stream of droplets of the jet ink composition to the surface, controlling the direction of the stream so that the droplets are caused to form the desired printed messages, and allowing the messages to dry.
Patent CA-2303804-A1 (CA)
Inventor: COPPING WILLIAM J
IPC: C25D5/02
Filed: 1998-10-02
Abstract: An apparatus and method for continuously electroplating metal webs by coating a masking ink thereto in a fashion resembling flexographic printing, then electroplating the uncoated areas of the web and finally removing the ink, is described. The masking ink is applied continuously from a reservoir to an "anilox" roller (46) which synchronously and rotatingly contacts either a plate roller (38) or an intermediate roller. Contact between the rollers transfers the masking ink from one roller to the other. The plate roller has "proud" or raised areas in which the ink is drawn and contacts a guided metal web (12) that is coated with the ink in a pattern matching that of the plate roller. Electroplating is effected after cleaning the inked web in an aqueous acid media. Finally, the masking ink is removed in an alkali medium.
Patent CA-2304259-A1 (CA)
Title: Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
Inventor: BEBBINGTON CHRIS
IPC: C12N1/21
Filed: 1998-09-23
Abstract: A retroviral vector is described. The retroviral vector comprises a functional splice donor site and a functional splice acceptor site; wherein the functional splice donor site and the functional splice acceptor site flank a first nucleotide sequence of interest ("NOI"); wherein the functional splice donor site is upstream of the functional splice acceptor site; wherein the retroviral vector is derived from a retroviral pro-vector; wherein the retroviral pro-vector comprises a first nucleotide sequence ("NS") capable of yielding the functional splice donor site and a second NS capable of yielding the functional splice acceptor site; wherein the first NS is downstream of the second NS; such that the retroviral vector is formed as a result of reverse transcription of the retroviral pro-vector.
Patent CA-2304302-A1 (CA)
Title: Resource management system
Inventor: ODGERS BRIAN ROBERT
IPC: G06Q10/00
Filed: 1998-10-01
Abstract: A resource handling system (120) has an intelligent software agent-based layer which provides a quasi-centralised control. The system has an interface to a user community and receives resource requests (115). There are multiple agents which negotiate to provide a response. The response can be substantially in real-time, rather than via a planning and scheduling capability, while there is also management of over- and under-bidding by the agents.
Patent CA-2307078-A1 (CA)
Inventor: LAMBRECHT STEFAN
IPC: A23L27/00
Filed: 2000-04-28
Abstract: A flavor composition comprising 8-ocimenyl esters of the formula (see formula I) wherein one of the two radicals R1 and R2 is methyl and the other is vinyl and one of the two radicals R3 and R4 is methyl and the other is (see formula II) wherein R5 is hydrogen, alkyl or alkenyl. Such flavor composition can also be mint and/or fruit flavor compositions, wherein the 8-ocimenyl esters have a flavor-enhancing action.
Patent CA-2309236-A1 (CA)
Inventor: PEZACKI JOHN
IPC: A61K38/00
Filed: 2000-05-24
Abstract: There is provided cross-linked, nitrosylated hemoglobin having cross-links between hemoglobin sub-units so as to prevent its dissociation into units of molecular weight less than abut 64 kD, and containing S-nitrosyl -S-N=O groups on cysteine residues of its globin chains, constituting both an oxygen-transporting and NO-transporting composition for administration to mammalian patients.
Patent CA-2310447-A1 (CA)
Title: Methods and apparatus for determining beta radiation spectra
Inventor: CONTE ROLLAND RENE
IPC: G01N33/483
Filed: 1998-11-16
Abstract: .beta.- radiation emitted either by a reference sample containing a predetermined concentration of a selected compound having homeopathic and/or allopathic efficacy, or by a sample of fluid extracted from an unhealthy or healthy body, or by a mixture of a predetermined concentration of a selected compound having homeopathic and/or allopathic efficacy and fluid extracted from an unhealthy body, is measured using a counting means to obtain a spectrum. The counting means is in a predetermined orientation relative to the compound or fluid being measured. The resulting spectra are compared to assess ill-health and to select a homeopathic and/or allopathic medicinal composition for treating ill-health.
Patent CA-2311028-A1 (CA)
Title: Centrifugal air filter
Inventor: WESENICK JARED C
IPC: B01D45/16
Filed: 2000-06-08
Abstract: The present invention provides a centrifugal air filter suitable for extracting impurities suspended in air. The filter includes a front wall, a rear wall spaced from the front wall, and a perimeter wall joining the front and rear walls and forming a cavity therebetween. Dividers divide the cavity into a plurality of vortex chambers. Each vortex chamber has a pair of inlets proximal opposing chamber ends and formed in the filter front wall, and an outlet formed in the filter rear wall generally centrally disposed between the inlets. Each vortex chamber extracts impurities by directing the air along a helical path through the vortex chamber from the inlets to the outlet. Air enters the vortex chamber inlets in the front of the filter, end exits the vortex outlet at the rear of the filter in the same plane.
Patent CA-2311661-A1 (CA)
Title: Thickenable vinyl ester resin compositions
Inventor: CHTOUROU HALIM
IPC: C08F290/14
Filed: 2000-06-14
Abstract: A curable vinyl ester resin composition capable of undergoing B-staging at room temperature comprises (a) an unmodified vinyl ester resin; (b) a reactive diluent consisting of an ethylenically unsaturated monomer; (c) a free-radical curing agent; (d) a B-staging agent comprising a Group II metal oxide or hydroxide, or a mixture thereof; and (e) a thickening agent comprising an ester, a ketone, an aldehyde or a mixture thereof. The thickening agent coacts with the B-staging agent to cause B-staging of the vinyl ester resin at room temperature. The vinyl ester resin composition according to the invention is particularly useful for impregnating a fibrous material such as a woven fabric material. The fibrous material impregnated with the vinyl ester resin composition of the invention has a shelf life of up to 12 months. B-stage is generally reached in about two weeks following mixture of the various components and impregnation of the fibrous material.
Patent CA-2312868-A1 (CA)
Inventor: SCHWEIGER MARTIN
IPC: G01G21/28
Filed: 1998-12-16
Abstract: The invention relates to a scale (20) having two force meter devices (21, 22) which independently of each other can be subjected to a weight and a display device (32) for indicating the sum of the weights. The force meter devices (21, 22) are connected to each other in such a way that the one force meter device (21) can rotate in relation to the other force meter device (22). This design allows for the force meter devices (21, 22) to be folded up and thus makes the scale easy to transport. The invention provides for three sensors (34, 35, 36) at the level of the force meter devices (21, 22).
Patent CA-2314223-A1 (CA)
Title: Suction powered cleaner for swimming pools
Inventor: SARGENT RONALD J
IPC: E04H4/16
Filed: 1999-08-23
Abstract: An improved suction powered cleaner (10) is provided for vacuuming dirt and debris from submerged floor and side wall surfaces of a swimming pool. The cleaner comprises a head (30) defining a suction inlet (34) for vacuum inflow into a plenum chamber (40), and further through a primary suction tube (42) adapted for connection via a vacuum hose (14) to a conventional pool water filtration system (12). An oscillatory main control valve (16) is pivotally mounted at an upstream end of the primary suction tube and spring-loaded toward a normal open position. The cleaner head may also include a bypass suction tube (104) having a normally closed bypass valve (106) responsive to pressure fluctuations within the primary suction tub. A perforated flexible disk (36) is carried by and extends radially outwardly from the cleaner head, and a laterally extending part-circle steering apron (132) overlies a segment of the disk so that the disk is vacuum-retained against the submerged surface.
Patent CA-2314621-A1 (CA)
Title: Procede pour l'obtention d'un module incluant un bobinage inductif et module correspondant
Inventor: VENET NORBERT
IPC: H01F27/40
Filed: 2000-07-05
Abstract: Procédé pour l'obtention d'un module comportant au moins un bobinage constit ué de pistes conductrices réalisées sur circuit imprimé et module (1) obtenu. le procédé implique - un empilage d'éléments modulaires de film de circuit imprimé (3A, 3N); - un moulage de l'ensemble formé par l'empilage d'éléments modulaires en un bloc rigide ; - au moins une opération de découpe du bloc moulé, latéralement au long de l'empilage, pour mettre à nu des pistes conductrices qui se terminent à un même niveau d'alignement et les faire affleurer en surface du bloc au niveau d'une face ; - une opération de création de connexions sur la ou les faces du bloc où affleurent des pistes conductrices d'éléments modulaires pour une interconnexion sélective de cep dernières et pour leur raccordement à des moyens de connexion externes au module.
Patent CA-2316212-A1 (CA)
Inventor: VOCK CURTIS A
IPC: G06V10/772
Filed: 1999-10-04
Abstract: Une caméra numérique (12) se connecte à un sous-système d'analyse des nuances des dents, comme par exemple un processeur vidéo (14), et un moniteur de visualisation en couleur pour la détermination électronique de la couleur des dents du patient. La caméra capture (26) d'abord une série d'images numériques en couleur des nuances des dents, correspondant aux nuanciers de référence (34) et compare électroniquement les nuances de référence à une image de la dent du patient. Dans un mode de réalisation préféré, la comparaison s'effectue sur un ensemble de pseudo-pixels correspondant chacun à un groupe de pixels dans une caméra à haute résolution. Une fois la correspondance trouvée, elle est communiquée à un utilisateur du système (52). Dans un mode de réalisation spécifique, la caméra est équipée d'une gaine et de sous-systèmes d'éclairage permettant la réduction des variations de couleur des images numériques, induites par des facteurs externes.
Patent CA-2319962-A1 (CA)
Inventor: EGERMANN PATRICK
IPC: G01N33/24
Filed: 2000-09-19
Abstract: - Méthode pour déterminer plus rapidement certains paramètres physiques (courbes de pression capillaire et perméabilités relatives par exemple) d'un échantillon géologique initialement saturé avec un premier fluide placé dans  un récipient et soumis à centrifugation en présence d'un deuxième fluide. - Par le biais d'une modélisation analytique mettant en jeu des fonctions exponentielles, s'ajustant au mieux à une courbe de production effective, po ur chaque palier de vitesse, on détermine les saturations d'équilibre bien avan t d'atteindre la complète stabilisation. On utilise une base de données obtenu es par diverses simulations, pour obtenir les courbes de perméabilités relative s correspondant à l'échantillon centrifugé. - Applications à des mesures de caractéristiques pétrophysiques.
Patent CA-2321438-A1 (CA)
Inventor: WARENIUS HILMAR MEEK
IPC: C12P21/08
Filed: 1999-02-18
Abstract: Provided is a method for selecting a chemotherapeutic agent for treating cancer, which method comprises: (a) testing a sample comprising cells that substantially do not express p21 and/or in which p21 protein is substantially undetectable, or an extract therefrom for the level of expression of Cyclin D1 of for the abundance of Cyclin D1 protein; and (b) if Cyclin D1 is over expressed, and/or Cyclin D1 protein is present at elevated levels, selecting for treatment a chemotherapeutic agent comprising a taxane; (c) if Cyclin D1 is not over expressed and/or Cyclin D1 protein is substantially not present at elevated levels, selecting for treatment a chemotherapeutic agent comprising an agent other than a taxane. Also provided is a kit for selecting a chemotherapeutic agent for treatment, which kit comprises: (a) a means for identifying cells in which p21 is substantially not expressed and/or p21 protein is substantially undetectable; and (b) a means for testing for the level of expression of Cyclin D1 or for the abundance of Cyclin D1 protein in cells or in a sample therefrom.
Patent CA-2322764-A1 (CA)
Title: Therapeutic chemokine receptor antagonists
Inventor: GONG JIANG-HONG
IPC: A61K38/00
Filed: 1999-03-12
Abstract: The invention provides a variety of therapeutic uses for CXCR4 antagonists. In various embodiments, CXCR4 antagonists may be used as therapeutically as follows, or to manufacture a medicament for such therapeutic treatments: reducing interferon gamma production by T-cells, treatment of an autoimmune disease, treatment multiple sclerosis, treatment of cancer, inhibition of angiogenesis. The invention provides corresponding methods of medical treatment, in which a therapeutic dose of a CXCR4 antagonist is administered in a pharmacologically acceptable formulation. Accordingly, the invention also provides therapeutic compositions comprising a CXCR4 antagonist and a pharmacologically acceptable excipient or carrier. The CXCR4 antagonists for use in the invention may be peptide compounds comprising a substantially purified peptide fragment, modified fragment, analogue or pharmacologically acceptable salt of SDF-1.
Patent CA-2323786-A1 (CA)
Title: Procedes servant a diagnostiquer le cancer au moyen d'une toxine chimere
Inventor: BEN-YEHUDAH AMI
IPC: C07K7/23
Filed: 1999-03-24
Abstract: L'invention concerne des procédés servant à diagnostiquer le cancer au moyen d'une toxine chimère. Elle concerne, en particulier, l'utilisation d'une toxine chimère composée d'une hormone de libération de gonadotrophine (GnRH) et d'une exotoxine A de Pseudomonas (PE) afin de détecter un déterminant antigénique associé à une tumeur et exprimé par des adénocarcinomes humains. Elle cite pour exemple des molécules de GnRH-PE ayant subi une mutation et qui se fixent aux cellules cancéreuses sans les détruire.
Patent CA-2325836-A1 (CA)
Inventor: BALDAUF WERNER
IPC: E04F/
Filed: 2000-11-14
Abstract: In a lift for small goods with a self-supporting guide construction (8), which comprises at least two corner profile members (9) and several stopping places with vertically sliding doors (25, 26) and along which a cage (12) is movable in vertical direction, it is proposed for manufacture and assembly favourable in cost to form the cage guide rails (40) by vertical edges of the corner profile members (9) so that separate guide rails for the cage (12) are superfluous. In one embodiment of the invention, four corner profile members (9) are connected together by means of horizontally and diagonally arranged struts (10, 11). A lateral displacement of the cage guide plane (13) by bent-over edge portions of the corner profile members (9) enables a saving in the support area of the lift. A  continuous two-row perforation (32) of the corner profile members (9) serves for the fastening of the struts (10, 11) and diverse attachment parts (35). The modular build-up of an embodiment of the invention with standardised corner profile pieces (36, 37) acts to lower the overall costs and facilitates the assembly of the lift installation according to the invention.
Patent CA-2325873-A1 (CA)
Title: Procede de peuplement de rubriques en matrices creuses a partir de donnees correspondantes et appareil a cet effet
Inventor: ROGERS JAMES P
IPC: G06F17/30
Filed: 1999-11-03
Abstract: La présente invention concerne un système permettant de sélectionner une table de données (20) appropriée utilisée comme base pour calculer une demande d'agrégation à partir d'un ensemble de tables de données (22) agrégées stockées. Le temps de traitement requis pour agréger chacune de ces tables est estimé, et celle qui correspond à l'estimation la plus basse est alors retenue pour réaliser l'agrégation.
Patent CA-2329043-A1 (CA)
Title: Porous structure comprising fungi cell walls
Inventor: EDEBO LARS
IPC: A61F13/15
Filed: 1999-04-16
Abstract: The present invention relates to a porous structure of prepared fungal cell wall components, whereby the cell wall material is derived from a fungi selected from the division Zygomycota, the fungal material in the form of a suspension is subjected to drying in such a way that the material obtains a porous structure, the structure has a liquid absorbing property which is at least 15 ml/g of 1 % NaCl (aq) and it has a liquid transporting ability of water, at a density of 0.01 to 0.03 g/cm3, in a horizontal direction of at least 10 mm during the first minute of absorption and in a vertical direction of at least 5 mm during a first minute of absorption.
Patent CA-2331104-A1 (CA)
Inventor: OHTA KENJI
IPC: G11B23/03
Filed: 2000-03-03
Abstract: A disc cartridge includes a disc casing having a disc chamber defined therein for rotatably accommodating the recording medium. The disc casing has a sensor hole and a slot defined in first and second wall portions of the casing that are opposed to each other. A safety device is disposed within the disc casing for preventing information recorded on the erasable recording medium from being erased inadvertently. The safety device includes a bearing bushing integral with the first wall portion, and a switching element connected at one end rotatably with the bearing bushing for angular movement between first and second operative positions. The sensor hole is adapted to be closed by the switching element when the latter is angularly moved to the first operative position.
Patent CA-2331501-A1 (CA)
Inventor: OLMESKOG STELLAN
IPC: A61K8/00
Filed: 1999-05-12
Abstract: L'invention concerne une composition comprenant 2 à 8 % de squalane, 1,5 à 8 % de cyclodextrine et 1,5 à 8 % d'un acide acceptable sur le plan pharmaceutique et/ou cosmétique, choisi parmi les acides mono, di et .alpha.-hydroxy-carboxyliques aliphatiques renfermant 2 à 10 atomes de carbone. Le solde peut être représenté par d'autres substances compatibles, possédant une activité anti-acné, acceptables sur le plan pharmaceutique et/ou cosmétologique, ou bien par des excipients et des additifs de pâte, de crème ou de pommade, acceptables sur le plan pharmaceutique et/ou cosmétologique. Cette composition, qui a un effet thérapeutique et cosmétique, peut être utilisée comme cosmétique ou pour la préparation d'un médicament destiné à la prophylaxie et au traitement de l'acné. L'invention concerne également un procédé de préparation de ladite composition, ainsi qu'une méthode de traitement de l'acné.
Patent CA-2332331-A1 (CA)
Title: Traitement de tumeurs humaines a l'aide d'un rayonnement et d'inhibiteurs de tyrosine kinases de recepteurs du facteur de croissance
Inventor: ROBERT FRANCISCO
IPC: C07K16/28
Filed: 1999-05-14
Abstract: L'invention concerne un procédé servant à inhiber la croissance de tumeurs chez des patients humains, qui comporte l'étape consistant à traiter les patients humains à l'aide d'une quantité efficace de rayonnement combiné à un inhibiteur de tyrosine kinase de récepteurs protéinique non radiomarqué, la surexpression de celle-ci pouvant entraîner la formation de tumeurs.
Patent CA-2332839-A1 (CA)
Inventor: HATA KIMIYO
IPC: C08F8/14
Filed: 2000-03-22
Abstract: A novel polymer which is a polymer having polyvinyl alcohol units and an average degree of polymerization of 20 or higher and in which part or all of the hydroxyl groups contained in the polyvinyl alcohol units have been replaced with an oxyalkylene-containing group having an average molar degree of substitution of 0.3 or higher; a binder resin comprising the polymer; an ionically conductive polymer electrolyte composition combining high ionic conductivity and high tackiness; and a secondary battery.